Home / Business and Economy / UnitedHealth Sells 164 Hospice and Home Health Sites to Resolve Antitrust Issues
UnitedHealth Sells 164 Hospice and Home Health Sites to Resolve Antitrust Issues
7 Aug
Summary
- UnitedHealth to sell 164 hospice and home health locations
- Deal resolves U.S. antitrust concerns over $3.3B Amedisys acquisition
- Justice Department fines UnitedHealth $1.1M for merger review issues
On August 7, 2025, UnitedHealth Group announced that it has agreed to sell off 164 hospice and home health locations to resolve U.S. antitrust concerns over its $3.3 billion acquisition of Amedisys. The Justice Department and attorneys general from four states had sued last year to block the deal, arguing it would reduce competition in the home health services market.
The settlement protects "quality and price competition for hundreds of thousands of vulnerable patients and wage competition for thousands of nurses," said Justice Department antitrust head Gail Slater. A spokesperson for Optum, UnitedHealth's healthcare provider unit, stated that the company looks forward to "continuing meaningful improvements in the home health and hospice care space" through the Amedisys acquisition.
In addition to the divestitures, the Justice Department also fined UnitedHealth $1.1 million for failing to provide complete information during the merger review process. This deal is the latest to be cleared by the Trump administration's antitrust enforcers, who have shown a greater willingness to approve mergers compared to their counterparts in the Biden administration.
